No Data
No Data
Erasca's Strong Clinical Data and Enhanced Financial Position Support Buy Rating
Erasca Secures Funding for Future Growth Through Private Placement
Express News | Erasca Shares Are Trading Higher After the Company Announced a $45 Million Private Placement Financing
Erasca Shares Climb After 4Q Loss Narrows, $45 Million Private Placement
By Dean Seal Shares of Erasca jumped after the company narrowed its loss in the fourth quarter and nabbed $45 million in an oversubscribed private placement. The stock was up 13% at $2.33 in premark
Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Erasca (ERAS)
HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $8 Price Target
HC Wainwright & Co. analyst Andres Maldonado reiterates Erasca with a Buy and maintains $8 price target.
No Data